Steel Stocks Surge on Extension of Minimum Import Price on 66 Steel Products
Beyond to Acquire Buy Buy Baby Brand Rights Reuniting It with Bed Bath Beyond
Preah Vihear Temple Attacks May Undermine Global World Heritage Protections
Unity U and Meta META Strengthen LongTerm VR Platform Support and Enterprise Partnership
Jay Thakkar Recommends Three FO Stocks for ShortTerm as Nifty Faces Resistance at 24100
BlockCon Punta Cana Announces Global Business Retreat for Web3 iGaming and Finance Convergence
Research Solutions Inc RSSS Q1 2026 Earnings EPS Falls Short as Shares Edge Higher
EVI Q1 2026 Earnings Significant EPS Miss Drags Stock Lower
MPC Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Performance and Margin Expansion
DIOD Q1 2026 Earnings EPS Surges Past Estimates Stock Climbs 35
THR Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Drops Nearly 7
SOPA Q3 2025 Earnings Massive EPS Miss Revenue Unreported Stuns Market
X3 Acquisition Corp XCBEU Holds Steady at 1002 as SPAC Units Trade Near Trust Value
JELDWEN Shares Surge 13 as Stock Rebounds from Key Support
Cheetah Net Supply Chain Service CTNT Slides 556 as Shares Test Key Support Levels
Range Capital Acquisition Corp II Warrants RNGTW Hold Steady at 032 Amid Quiet Trading
Asbury Automotive Group ABG Holds Steady Near Resistance on Modest Gains
SpaceX Faces Crucial Launch Test as IPO Speculation Intensifies
MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline
SentinelOne S Faces Resistance Can the Cybersecurity Stock Rebound from Latest Dip
Renatus Tactical Acquisition Corp I Unit RTACU Edges Higher Amid Consolidation
Distribution Solutions Group DSGR Holds Steady as Shares Trade Near Range Midpoint
Thayer Ventures Acquisition Corp II TVAI Holds Steady at 1029 as Market Awaits Catalyst
Smart Share Global EM Consolidates Near Key Levels as Traders Await Catalyst
GIBO Holdings GIBO Edges Higher Key Support and Resistance Levels in Focus
KVAC Holds Steady Near Midpoint as SPAC Investors Weigh Next Move
Royalty Pharma RPRX Edges Higher Testing Resistance Near 57 Amid Steady Gains